Communications with Pfizer
Andy Hooley made this Official Information request to Ministry of Health
The request was partially successful.
From: Andy Hooley
Dear Ministry of Health,
Can you please provide all communications from this government that have been directed to and received from any representative from the company called Pfizer in relation to the Comirnaty vaccine or with any connection to the covid19 virus in the period 01/01/18 to present day 25/05/21.
Yours faithfully,
Andy Hooley
From: OIA Requests
Kia ora
Thank you for your request for official information received 25 May 2021
2021 for:
" Can you please provide all communications from this government that have
been directed to and received from any representative from the company
called Pfizer in relation to the Comirnaty vaccine or with any connection
to the covid19 virus in the period 01/01/18 to present day 25/05/21."
The Ministry's reference number for your request is: H202106403.
As required under the Official Information Act 1982 we will endeavour to
respond to your request no later than 23 June 2021, being 20 working days
after the day your request was received.
If we are unable to respond to your request within this time frame, we
will notify you of an extension of that time frame.
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngā mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [email address]
show quoted sections
From: Vince Neaves
Kia ora,
Thank you for your request for official information, received on 25 May
2021 for:
" Can you please provide all communications from this government that have
been directed to and received from any representative from the company
called Pfizer in relation to the Comirnaty vaccine or with any connection
to the covid19 virus in the period 01/01/18 to present day 25/05/21”
We are contacting you in accordance with section 18B of the Official
Information Act 1982 (the Act) as your request, as it is currently worded,
is for a very large volume of information. Your request may be refused
under section 18(f) of the Act as the information requested cannot be made
available without substantial collation or research.
We are proposing to refine the scope of your request to 1 October 2020 to
7 April 2021.
Please respond by 8 June 2021 if this date range works. This way we can
consider the refinement in our response to your request.
We look forward to receiving your response.
Ngâ mihi
Vince Neaves
Advisor | OIAServices
Office of the Director-General
Ministry of Health
E: [1][email address]
L1 North, Yellow, 113 Molesworth St, Wellington
show quoted sections
References
Visible links
1. mailto:[email address]
Mr Rodgers left an annotation ()
Andy - you need to reply to MoH and not add an annotation. They might not come onto the fyi website to see your reply.
From: Andy Hooley
Dear Vince Neaves,
Yes, if that will be sufficient at this stage. Thanks.
Yours sincerely,
Andy Hooley
From: Andy Hooley
Dear Vince Neaves,
Yes, if that will be sufficient at this stage. Thanks.
Yours sincerely,
Andy Hooley
From: Andy Hooley
Dear Vince Neaves,
Yes, if that will be sufficient at this stage. Thanks.
Yours sincerely,
Andy Hooley
From: OIA Requests
Kia ora
Thank you for refining your request for official information on 02 June 2020 to have the following timeframe: 1 October 2020 to 7 April 2021.
Please note, under section 15 of the Official Information Act 1982, any clarification or amendments made to a request within seven days after the date it is received, that request may be treated as a new request and the time limit for the response restarts.
You can now expect a response by 01 July 2020.
Nga mihi,
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [email address]
show quoted sections
From: Vince Neaves
Kia ora Andy,
Thank you for your request for official information, received on 25
May 2021 for:
“All communications from this government that have been directed to and
received from any representative from the company called Pfizer in
relation to the Comirnaty vaccine or with any connection to the covid19
virus in the period 01/01/18 to present day 25/05/21”
The request was refined on 2 June 2021 to:
“a date range of 1 October 2020 to 7 April 2021.”
We are contacting you in accordance with section 18B of the Official
Information Act 1982 (the Act) as I have been advised that your request,
as it is currently worded, is for a very large volume of information. We
could only supply you with part of this information and some of your
request may be refused under section 18(f) of the Act as the information
requested cannot be made available without substantial collation or
research.
We are currently preparing the information for October, November and
December 2020 with the intention of preparing and releasing the
information for January, February, and March 2021 at a later date.
Would it be acceptable to refine the scope of your request to:
“All correspondence between Pfizer and the Ministry of Health for October,
November and December 2020”
Please respond before 5:00pm today so that we can consider your
refinement in our response to your request.
We look forward to receiving your response.
Ngâ mihi
Vince Neaves
Advisor | OIAServices
Office of the Director-General
Ministry of Health
E: [1][email address]
L1 North, Yellow, 113 Molesworth St, Wellington
show quoted sections
References
Visible links
1. mailto:[email address]
From: OIA Requests
Kia ora Andy,
Please find attached a letter regarding your request for information.
Ngā mihi,
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [1][email address]
show quoted sections
References
Visible links
1. mailto:[email address]
D J Blair left an annotation ()
Corporate secrecy in medicine has come to implicate public interests—including interests in access to information about products and corporate behaviour—that are essential to democracy and the public good. Those who describe the incentive effects of trade secrets law rarely consider these broad public implications, the measures that may be needed to ensure that trade secrets do not overprotect information that would be created anyway, or the law’s interference with important public interests.
Access to medicines is integral to the right to health. Today, commercial actors utilize trade secrecy to hide numerous types of health-related data, including clinical trial data, engineering and manufacturing data, data related to algorithms and machine learning, pricing data, and information on corporate wrongdoing. The consequences for access to medicines, and thus human rights, are significant, undermining patient-level health, the development of affordable treatments, and the effectiveness of health systems as a whole. By guarding against the entrenchment of trade secret law as creating “rights” protected under international and domestic law, by protecting the public interest in confidential commercial information by allowing or mandating data sharing, and by strengthening whistle-blower protections, countries can protect the pressing public need for collaboration and transparency. In so doing, New Zealand can expand access to medicines and promote the right to health
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this request
Andy Hooley left an annotation ()
Yes, if that will be sufficient at this stage. Thanks.
Link to this